Abstract
The use of electrotransfer to deliver therapeutic agents such as cytotoxic drugs and nucleic acids to cells and tissues has been successfully developed over the last decade. This strategy is promising for the systemic secretion of therapeutic proteins, vaccination and gene therapy. The safe and efficient use of this physical method for clinical purposes requires knowledge of the mechanisms underlying the DNA electrotransfer and expression phenomena. Despite the fact that the pioneering work on plasmid DNA electrotransfer to cells was initiated 30 years ago, many of the underlying mechanisms remain elucidated. While efficient in vitro, the method faces a lack of efficiency in packed tissues. Until now, the great majority of studies have been performed on cells in 2D cultures in Petri dishes or in suspension. However, these studies cannot get access to the tissue-specific architecture and organization present in 3D living tissues. In this context, 3D cell culture models are more relevant concerning in vivo cell organization since cell-cell contacts are present as well as extracellular matrix. The aim of this review is to describe the relevance of using spheroid as a model to address and improve the electrotransfer processes.
Keywords: 3D, DNA transfer, electropermeabilization, electroporation, model, spheroid.
Current Gene Therapy
Title:Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer
Volume: 13 Issue: 3
Author(s): Laure Gibot and Marie-Pierre Rols
Affiliation:
Keywords: 3D, DNA transfer, electropermeabilization, electroporation, model, spheroid.
Abstract: The use of electrotransfer to deliver therapeutic agents such as cytotoxic drugs and nucleic acids to cells and tissues has been successfully developed over the last decade. This strategy is promising for the systemic secretion of therapeutic proteins, vaccination and gene therapy. The safe and efficient use of this physical method for clinical purposes requires knowledge of the mechanisms underlying the DNA electrotransfer and expression phenomena. Despite the fact that the pioneering work on plasmid DNA electrotransfer to cells was initiated 30 years ago, many of the underlying mechanisms remain elucidated. While efficient in vitro, the method faces a lack of efficiency in packed tissues. Until now, the great majority of studies have been performed on cells in 2D cultures in Petri dishes or in suspension. However, these studies cannot get access to the tissue-specific architecture and organization present in 3D living tissues. In this context, 3D cell culture models are more relevant concerning in vivo cell organization since cell-cell contacts are present as well as extracellular matrix. The aim of this review is to describe the relevance of using spheroid as a model to address and improve the electrotransfer processes.
Export Options
About this article
Cite this article as:
Gibot Laure and Rols Marie-Pierre, Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer, Current Gene Therapy 2013; 13 (3) . https://dx.doi.org/10.2174/1566523211313030002
DOI https://dx.doi.org/10.2174/1566523211313030002 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Estrogen Receptor-α: Plasma Membrane Localization and Functions
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals
Anti-Cancer Agents in Medicinal Chemistry Interaction Between Estrogen Receptor Alpha and Insulin/IGF Signaling in Breast Cancer
Current Cancer Drug Targets Subcellular Imaging and Diagnosis of Cancer using Engineered Nanoparticles
Current Pharmaceutical Design Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Current Medicinal Chemistry Transcriptome Analysis of mRNA in Uterine Leiomyoma Using Next-generation RNA Sequencing
Anti-Cancer Agents in Medicinal Chemistry An Overview on 2-arylquinolin-4(1H)-ones and Related Structures as Tubulin Polymerisation Inhibitors
Current Topics in Medicinal Chemistry The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids
Anti-Cancer Agents in Medicinal Chemistry How to Inhibit Telomerase Activity for Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Anti-Cancer Targeting Telomerase Inhibitors: β-Rubromycin and Oleic Acid
Mini-Reviews in Medicinal Chemistry Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Structure-Activity Relationship of Nuclear Receptor-Ligand Interactions
Current Topics in Medicinal Chemistry Inflammation and Thrombophilia in Pregnancy Complications: Implications for Risk Assessment and Clinical Management
Cardiovascular & Hematological Disorders-Drug Targets Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Construction and Comprehensive Analysis of a Special Competitive Endogenous RNAs Network to Reveal Potential Prognostic Biomarkers for Endometrial Carcinoma
Current Bioinformatics Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Current Cancer Drug Targets The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
Current Pharmaceutical Design Autophagy: Molecular Mechanisms and their Implications for Anticancer Therapies
Current Cancer Drug Targets